SynthesisSystematic reviews2025
Incidence of loss to follow‑up among East African adults on antiretroviral therapy: a systematic review and meta‑analysis.
Synthesis in Systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndividuals with human immunodeficiency virus receive antiretroviral treatment regardless of their clinical stage or CD4 count. While the "Universal Test and Treat" approach offers benefits, loss to follow-up remains a significant issue in sub-Saharan Africa, especially in East African countries, hindering treatment program goals. Due to inconsistent findings in previous studies, policymakers and healthcare providers struggle to implement effective interventions. This study aims to provide a pooled incidence of loss to follow-up among East African adults on antiretroviral therapy.
methodsA systematic review and meta-analysis were conducted among East African adults on antiretroviral therapy. Literature was sought from PubMed, Embase, Scopus, Cochrane, and Web of Science. Additionally, we conducted hand-searching of reference lists and citation tracking of included studies. The review encompassed both retrospective and prospective follow-up articles published in English. The data extraction was completed using Covidence software and later transferred to Stata™ Version 18.0 for further analysis. Heterogeneity was evaluated with the aid of forest plots with the I
resultsThe current meta-analysis examined 20 studies that satisfied the eligibility criteria out of the 3011 studies examined involving a total of 54,388 adults receiving antiretroviral therapy. The pooled analysis of these 20 studies established an overall incidence of loss to follow-up of 9.67 per 100 person-years of observation (95% CI, 7.84, 11.93) with I
conclusionsAmong adult East Africans on antiretroviral therapy, the loss to follow-up rate is projected to fail to meet the requirement set by the UN. Such insight can assist in formulating policies by identifying important factors that can help retain adults with HIV in lifelong antiretroviral treatment services. SYSTEMATIC REVIEW REGISTRATION: CRD42024568267.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.